These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 7872363

  • 1. Considerations on the sodium retention in nephrotic syndrome.
    Usberti M, Gazzotti RM, Poiesi C, D'Avanzo L, Ghielmi S.
    Am J Nephrol; 1995; 15(1):38-47. PubMed ID: 7872363
    [Abstract] [Full Text] [Related]

  • 2. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B.
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [Abstract] [Full Text] [Related]

  • 3. Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention.
    Hensen J, Abraham WT, Dürr JA, Schrier RW.
    Am J Nephrol; 1991 Apr; 11(6):441-6. PubMed ID: 1840232
    [Abstract] [Full Text] [Related]

  • 4. Hyporeninemic hypoaldosteronism in patients with nephrotic syndrome.
    Usberti M, Gazzotti RM.
    Am J Nephrol; 1998 Apr; 18(3):251-5. PubMed ID: 9627045
    [Abstract] [Full Text] [Related]

  • 5. Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome.
    Plum J, Mirzaian Y, Grabensee B.
    Nephrol Dial Transplant; 1996 Jun; 11(6):1034-42. PubMed ID: 8671965
    [Abstract] [Full Text] [Related]

  • 6. The atrial natriuretic peptide-renin-aldosterone system in hepatorenal syndrome.
    Pasqualetti P, Casale R.
    Riv Eur Sci Med Farmacol; 1996 Jun; 18(4):137-41. PubMed ID: 9177611
    [Abstract] [Full Text] [Related]

  • 7. [Renal tubular function in cirrhotic patients with ascites: special reference to lithium clearance following the human atrial natriuretic peptide administration].
    Ando M.
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):791-801. PubMed ID: 1837568
    [Abstract] [Full Text] [Related]

  • 8. Effects of plasma volume expansion on renal salt handling in patients with the nephrotic syndrome.
    Koomans HA, Geers AB, vd Meiracker AH, Roos JC, Boer P, Dorhout Mees EJ.
    Am J Nephrol; 1984 Aug; 4(4):227-34. PubMed ID: 6383042
    [Abstract] [Full Text] [Related]

  • 9. Effect of posture on sodium excretion and diuretic efficacy in nephrotic patients.
    Minutolo R, Andreucci M, Balletta MM, Russo D.
    Am J Kidney Dis; 2000 Oct; 36(4):719-27. PubMed ID: 11007673
    [Abstract] [Full Text] [Related]

  • 10. Sodium retention in nephrotic syndrome is due to an intrarenal defect: evidence from steroid-induced remission.
    Brown EA, Markandu N, Sagnella GA, Jones BE, MacGregor GA.
    Nephron; 1985 Oct; 39(4):290-5. PubMed ID: 3982574
    [Abstract] [Full Text] [Related]

  • 11. Plasma atrial natriuretic peptide and natriuretic response to water immersion in patients with nephrotic syndrome.
    Hwang SJ, Tsai JH, Lai YH, Chen JH.
    Nephron; 1991 Oct; 58(3):330-8. PubMed ID: 1832746
    [Abstract] [Full Text] [Related]

  • 12. Role of aldosterone in the sodium retention of patients with nephrotic syndrome.
    Shapiro MD, Hasbargen J, Hensen J, Schrier RW.
    Am J Nephrol; 1990 Oct; 10(1):44-8. PubMed ID: 2188506
    [Abstract] [Full Text] [Related]

  • 13. Effect of frusemide on atrial natriuretic peptide, guanosine cyclic monophosphate, angiotensin II, aldosterone, vasopressin, prostaglandin E2 and blood volume in the nephrotic syndrome.
    Jespersen B, Sørensen SS, Pedersen EB.
    Nephrol Dial Transplant; 1991 Oct; 6(6):402-9. PubMed ID: 1652115
    [Abstract] [Full Text] [Related]

  • 14. Atrial natriuretic peptide and other vasoactive hormones in nephrotic syndrome.
    Tulassay T, Rascher W, Lang RE, Seyberth HW, Schärer K.
    Kidney Int; 1987 Jun; 31(6):1391-5. PubMed ID: 2956451
    [Abstract] [Full Text] [Related]

  • 15. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate.
    Jespersen B, Eiskjaer H, Mogensen CE, Sørensen SS, Pedersen EB.
    Nephron; 1995 Jun; 71(1):44-53. PubMed ID: 8538848
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system.
    Eiskjaer H, Bagger JP, Danielsen H, Jensen JD, Jespersen B, Thomsen K, Sørensen SS, Pedersen EB.
    Am J Physiol; 1991 Jun; 260(6 Pt 2):F883-9. PubMed ID: 1647690
    [Abstract] [Full Text] [Related]

  • 17. Is the renin-angiotensin-aldosterone system involved in the sodium retention in the nephrotic syndrome?
    Brown EA, Markandu ND, Roulston JE, Jones BE, Squires M, MacGregor GA.
    Nephron; 1982 Jun; 32(2):102-7. PubMed ID: 6757778
    [Abstract] [Full Text] [Related]

  • 18. An abnormal sodium metabolism in Japanese patients with essential hypertension, judged by serum sodium distribution, renal function and the renin-aldosterone system.
    Komiya I, Yamada T, Takasu N, Asawa T, Akamine H, Yagi N, Nagasawa Y, Ohtsuka H, Miyahara Y, Sakai H, Sato A, Aizawa T.
    J Hypertens; 1997 Jan; 15(1):65-72. PubMed ID: 9050972
    [Abstract] [Full Text] [Related]

  • 19. Evidence that some mechanism other than the renin system causes sodium retention in nephrotic syndrome.
    Brown EA, Markandu ND, Sagnella GA, Squires M, Jones BE, MacGregor GA.
    Lancet; 1982 Dec 04; 2(8310):1237-40. PubMed ID: 6128546
    [Abstract] [Full Text] [Related]

  • 20. Modulation of natriuresis and renal dopamine excretion by sympathetic activity and the renin-angiotensin-aldosterone system.
    Barendregt JN, van Nispen tot Pannerden LA, Chang PC.
    J Hum Hypertens; 1994 Oct 04; 8(10):747-54. PubMed ID: 7837211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.